Crude Oil Drops Over 2%; Akouos Shares Spike Higher

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 300 points on Tuesday.

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 300 points on Tuesday.

The Dow traded up 1.02% to 30,492.91 while the NASDAQ rose 0.57% to 10,736.71. The S&P 500 also rose, gaining, 0.94% to 3,712.55.

Also check this: Fear & Greed Index Moves To 'Fear' Zone After Dow Jumps 550 points

Leading and Lagging Sectors

Industrials shares climbed 2.1% on Tuesday. Leading the ADSE).

In trading on Tuesday, health care shares rose by just 0.4%.

Top Headline

 

The Goldman Sachs Group, Inc. (NYSE:GS) reported better-than-expected Q3 results.

Goldman Sachs Group posted quarterly sales of $11.98 billion, versus market estimates of $11.43 billion.

 

Equities Trading UP

 

  • Akouos, Inc. (NASDAQ:LLY) agreed to acquire Akouos for a 78% premium over Monday’s closing price of $7.01.
  • Shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) got a boost, shooting 41% to $14.77 after LG Chem announced it will acquire AVEO Oncology for $15 per share in cash.
  • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares were also up, gaining 24% to $2.34 after the company announced plans to initiate a second clinical trial in Netherton Syndrome patients.

Equities Trading DOWN

  • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) shares tumbled 43% to $2.83 after the company announced a pause in new patient enrollment in its Phase 1/2 trial of seclidemstat in Ewing Sarcoma and FET-rearranged sarcomas following the death of a patient.
  • Shares of Cosmos Holdings Inc. (NASDAQ:COSM) were down 47% to $0.0799 after the company announced pricing of a $7.5 million upsized public offering at $0.12 per share.
  • Sierra Metals Inc. (NASDAQ:SMTS) was down, falling 38% to $0.3051 after the company provided a financial and operations update and announced a strategic review process.

Also check out: Bitcoin, Ethereum Record Gains; Here Are Other Crypto Movers That Should Be On Your Radar Today

Commodities

In commodity news, oil traded down 2.2% to $83.56, while gold traded down 0.5% at $1,655.90.

Silver traded down 0.6% to $18.605 on Tuesday while copper fell 1.6% to $3.3625.

Euro zone

European shares closed higher today. The eurozone’s STOXX 600 rose 0.34%, London’s FTSE 100 rose 0.24% while Spain’s IBEX 35 Index jumped 0.72%. The German DAX climbed 0.92%, French CAC 40 rose 0.44% and Italy’s FTSE MIB Index gained 0.93%.

Passenger car registrations in the European Union surged 9.6% year-over-year to 787,870 units in September. The ZEW Indicator of Economic Sentiment for the Eurozone rose to -59.7 in October versus September's 14-year low level of -60.7, while German ZEW Indicator of Economic Sentiment increased by 2.7 points to -59.2 in October.

Spanish trade deficit increased to EUR 7.94 billion in August from EUR 3.88 billion in the year-ago month, while Italy reported a trade deficit of EUR 9.57 billion in August versus a year-ago surplus EUR 1.02 billion.

 

Economics

 

  • Industrial production in the US rose 0.4% from a month ago in September versus a revised 0.1% decline in August and above analysts’ estimates of a 0.1% growth. Manufacturing production climbed 0.4% from a month ago in September.
  • The NAHB housing market index declined for the 10th consecutive month to a reading of 38 in October, down from market estimates of 43.
  • The Treasury International Capital report for August will be released at 4:00 p.m. ET.
  • Minneapolis Fed President Neel Kashkari will speak at 5:30 p.m. ET.

Check out this: Volatility In Markets Decreases Following Upbeat Bank of America Earnings

COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 98,877,880 cases with around 1,090,800 deaths. India confirmed a total of at least 44,632,430 cases and 528,910 deaths, while France reported over 36,268,020 COVID-19 cases with 155,980 deaths. In total, there were at least 630,430,620 cases of COVID-19 worldwide with more than 6,573,170 deaths.

 

Total
0
Shares
Related Posts
Read More

Verve Therapeutics Announces Interim Data For VERVE-101 Demonstrating First Human Proof-Of-Concept For In Vivo Base Editing With Dose-Dependent Reductions In LDL-C And Blood PCSK9 Protein In Patients With Heterozygous Familial Hypercholesterolemia

LDL-C Reductions Up to 55% and Blood PCSK9 Protein Reductions Up to 84% Observed After a Single Infusion of VERVE-101 at Potentially Therapeutic Doses Safety Profile Supports Continued Development of

VERV